Nesina (alogliptin)

pCPA File Number: 20872
Negotiation Status:
Negotiations were not pursued
Indication(s):
Diabetes Mellitus, Type 2
Sponsor/Manufacturer:
Takeda Canada Inc.
CDA-AMC Project Number:
SR0368-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: